- Award ID
- N0001924C0061
- Sub-agency / office
- Department of the Navy
- Award amount
- $587,386,007
- Period of performance
- Aug 26, 2024 – Aug 24, 2029
- NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- PSC AC14
- Place of performance
- SALT LAKE CITY, UT, 841160850, USA
- Competition
- FULL AND OPEN COMPETITION · Set-aside: NO SET ASIDE USED. · 2 offers
- Pricing
- COST PLUS INCENTIVE FEE
- Financial breakdown
- Current value $588,943,225 · Obligated $289,892,482 · Potential value $588,943,225 · Latest action obligation $0
Most recent · Modification P00018 · Jun 23, 2026 · $0 action obligation · THIS MODIFICATION UPDATES SECTION J ATT(3), AS WELL AS THE INSPECTION & ACCEPTANCE CRITERIA FOR CLIN 0014. · N0001924C0061
Modification P00017 · May 11, 2026 · $30,500,000 action obligation · THIS MODIFICATION INCREMENTALLY FUNDS CLINS 0001 & 0008. · N0001924C0061
Modification P00016 · Mar 19, 2026 · $50,000,000 action obligation · THIS MODIFICATION INCREMENTALLY FUNDS CLIN 0001. · N0001924C0061
Modification P00015 · Feb 24, 2026 · $5,000,000 action obligation · THIS MODIFICATION PROVIDES INCREMENTAL FUNDING UNDER CLIN 0001. · N0001924C0061
Modification P00014 · Jan 13, 2026 · $10,000,000 action obligation · THIS MODIFICATION PROVIDES INCREMENTAL FUNDING UNDER CLIN 0001. · N0001924C0061
Modification P00013 · Jan 6, 2026 · $0 action obligation · THIS NO-COST MODIFICATION UPDATES CLAUSE H-1 AND SECTION J EXS (A) & (B), AND ATTS (1), (2), AND (4). · N0001924C0061
Modification P00012 · Nov 20, 2025 · $22,000,000 action obligation · LB INCREMENTAL FUNDING · N0001924C0061
Modification P00011 · Sep 24, 2025 · $189,059 action obligation · THIS MODIFICATION INCREMENTALLY FUNDS CLIN 0001. · N0001924C0061
Modification P00010 · Aug 14, 2025 · $5,173,579 action obligation · THIS MODIFICATION INCREMENTALLY FUNDS CLIN 0001. · N0001924C0061
Modification P00009 · Jun 26, 2025 · $0 action obligation · THIS MODIFICATION UPDATES THE TPOC AND CLAUSE HTXT.245-0001. · N0001924C0061
Modification P00008 · May 19, 2025 · $19,575,962 action obligation · THIS MODIFICATION INCREMENTALLY FUNDS CLIN 0001. · N0001924C0061
Modification P00007 · May 15, 2025 · $0 action obligation · THIS MODIFICATION UPDATES SECTION J ATT (3) AND CLAUSES IN ACCORDANCE WITH EXECUTIVE ORDERS. · N0001924C0061
Modification P00006 · May 1, 2025 · $0 action obligation · THIS MODIFICATION AMENDS SECTION J EX(A) AND ATTS (1), (3), (8), & (9). THIS MODIFICATION ALSO INCORPORATES CLAUSE HTXT.245-0001 AND REMOVES/AMENDS CLAUSES IN ACCORDANCE WITH E.O. 14173. · N0001924C0061
Modification P00005 · Mar 10, 2025 · $25,000,000 action obligation · THIS MODIFICATION INCREMENTALLY FUNDS CLIN 0001. · N0001924C0061
Modification P00004 · Jan 28, 2025 · $12,000,000 action obligation · THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLIN 0001. · N0001924C0061
Modification P00003 · Dec 12, 2024 · $9,387,167 action obligation · THIS MODIFICATION INCREMENTALLY FUNDS CLIN 0001. · N0001924C0061
Modification P00002 · Dec 6, 2024 · $0 action obligation · ADMIN UPDATES TO SECTION F AND SECTION J · N0001924C0061
Modification P00001 · Sep 18, 2024 · $0 action obligation · ADD PAYMENT CLAUSE · N0001924C0061
Modification 0 · Aug 26, 2024 · $76,226,989 action obligation · NGJ LB CB1 DEVELOPMENT · N0001924C0061